JUVENILE XANTHOGRANULOMA

Clinical trials for JUVENILE XANTHOGRANULOMA explained in plain language.

Never miss a new study

Get alerted when new JUVENILE XANTHOGRANULOMA trials appear

Sign up with your email to follow new studies for JUVENILE XANTHOGRANULOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet finished but already full! 1

New hope for Tough-to-Treat rare diseases: experimental drug targets faulty cell signals

Disease control Recruiting now

This study is testing whether the drug cobimetinib can help control several rare disorders caused by overactive immune cells, particularly when standard treatments have failed. The trial will enroll 90 children and adults with conditions like Langerhans cell histiocytosis (LCH) a…

Matched conditions: JUVENILE XANTHOGRANULOMA

Phase: PHASE2 • Sponsor: Carl Allen • Aim: Disease control

Last updated Mar 17, 2026 12:55 UTC

JUVENILE XANTHOGRANULOMA

Get alerted when new JUVENILE XANTHOGRANULOMA trials appear

New hope for Tough-to-Treat rare diseases: experimental drug targets faulty cell signals